Transfection of RNA Encoding Tumor Antigens Following Maturation of Dendritic Cells Leads to Prolonged Presentation of Antigen and the Generation of High-Affinity Tumor-Reactive Cytotoxic T Lymphocytes
Open Access
- 31 May 2004
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (5), 757-764
- https://doi.org/10.1016/j.ymthe.2004.02.011
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Programmed contraction of CD8+ T cells after infectionNature Immunology, 2002
- Enhanced Dendritic Cell Antigen Presentation in RNA-Based ImmunotherapyJournal of Surgical Research, 2002
- Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cellsNature Biotechnology, 2002
- Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytesGene Therapy, 2000
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- In Vitro Analysis of Transformation Potential Associated with Retroviral Vector InsertionsHuman Gene Therapy, 1999
- Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsJournal of Clinical Investigation, 1999
- High Level of Retrovirus-Mediated Gene Transfer into Dendritic Cells Derived from Cord Blood and Mobilized Peripheral Blood CD34+ CellsHuman Gene Therapy, 1999
- Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNANature Biotechnology, 1998
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994